•  
  •  
  •  
  •  

2025-10-01 02:05:15

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores

Keywords Selected:  ANVISA

Stock Report

  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Hikal Ltd successfully completes ANVISA GMP audit of Jigani unit
  • Wanbury's Tanuku facility granted Good Manufacturing Practices Certificate by ANVISA
  • OneSource Specialty Pharma Ltd secures Brazilian GMP approval for its flagship facility Unit 2
  • Wanbury Limited successfully completes ANVISA audit at its Tanuku plant
  • Wanbury's Tanuku plant at Andhra Pradesh successfully completes ANVISA inspection
  • Alembic Pharmaceuticals Limited passes ANVISA, Brazil GMP audit for its API-II Facility at Panelav
  • Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection
  • IOL Chemicals and Pharmaceuticals Ltd receives GMP Certificate issued by Brazilian Health Regulatory Agency ANVISA
  • IOL Chemicals and Pharmaceuticals Ltd successfully completes ANVISA GMP audit
  • CARBOGEN AMCIS (Shanghai) Co Ltd. has successfully completed ANVISA Audit of its facility in Shanghai, China
  • ANVISA issues CGMP to Concord Biotech Ltd's Unit I
  • Supriya Lifesciences Ltd received GMP certification from ANVISA Brazil
  • Granules India Limited received approval from Brazilian Health Regulatory Agency ANVISA
  • Kwality Pharmaceuticals received ANVISA approval for Cephalosporin Plant, Unit -II
  • Alembic Pharmaceuticals Ltd passes ANVISA, Brazil GMP audit for its API-III Facility at Karakhadi
  • Kwality Pharmaceuticals receives approval from ANVISA for injectable unit

Latest Post

  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024